Search Results 951-960 of 18097 for Topical

1. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   NOTE: Use of inhaled or topical steroids is not exclusionary. Sorafenib/Regorafenib/Lenvatinib within 1 week;; Cabozantinib within 2 weeks;; Duration of ...

2. Publications - Nessa Aghazadeh Mohandesi, M.D. - Mayo Clinic

   2023 Jul; 62(7):938-945. Epub 2023 Mar 08. View PubMed; Sadeghi S, Mohandesi NA. Efficacy and safety of topical JAK inhibitors in the treatment of atopic ...

3. Progel Vascular Sealant - Clinical Trials

   Following this injection, subject has a leaking site where a topical sealant/hemostatic agent may be used to control bleeding. Exclusion Criteria: Subject ...

4. Phase 2b Study of Investigational Products in Participants with Interstitial Lung Disease Secondary to Systemic Sclerosis - Mayo Clinic

   Inhaled and topical corticosteroids are permitted. Refer to Appendix C for a corticosteroid dose conversion table. Women of childbearing potential (WOCBP) ...

5. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Inhaled or topical steroids and adrenal replacement doses < 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease.

6. Chemical peel - Mayo Clinic

   Chemical peels are used to treat wrinkles, discolored skin and scars — usually on the face. They can be done alone or combined with other cosmetic procedures.

7. A Study to Evaluate the Safety and Effectiveness of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa Evaluating the Safety and Effectiveness of PF-06650833, PF-06700841, and PF-06826647 in Adults with Moderate-to-Severe Hidradenitis Suppurativa - Mayo Clinic

   Participant must agree to daily use (and through follow-up) to one of the non-prescription topical antiseptics on their HS lesions such as: chlorhexidine ...

8. Polymyxin b and trimethoprim (ophthalmic route) - Side effects & dosage - Mayo Clinic

   Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Drug Interactions. Although certain medicines ...

9. Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer - Mayo Clinic

   Chemotherapy ≤ 6 months prior to randomization (Note: topical chemotherapy will be assessed on a case-by-case basis); Pregnant women; Nursing women; Men or ...

10. Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative Colitis - Mayo Clinic

    Topical, intranasal, or inhaled use is not exclusionary. Immunomodulator (6-mercaptopurine, azathioprine) use within 6 weeks prior to the Screening Visit ...